HUD Seeks Feedback on ROSS Program Data Collection Extension
Published Date: 5/11/2026
Notice
Summary
HUD wants to keep collecting info for the Resident Opportunities and Self-Sufficiency (ROSS) Program, which helps public housing residents improve their lives. They’re asking for public feedback by July 10, 2026, before getting final approval. This update won’t cost extra but keeps the program running smoothly for residents and communities.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
ROSS grant paperwork reinstated
HUD proposes to reinstate the Office of Management and Budget information collection (OMB Control No. 2577-0229) for the Resident Opportunities and Self-Sufficiency (ROSS) program and is accepting public comments by July 10, 2026. The collection requires applicants to submit forms such as HUD-52753, HUD-52755, and HUD-52768; HUD estimates about 350 respondents, a total annual burden of 186.25 hours, and an annual cost of $3,949.45.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16228, HUD's Implementation of the Fair Housing Act's Disparate Impact Standard; Amendments to HUD's Title VI Regulations
HUD published a notice of proposed rulemaking in January of 2026 that proposed to remove HUD's disparate-impact regulations and leave interpretation of disparate-impact liability under the Fair Housing Act to the courts. This supplemental notice of proposed rulemaking continues HUD's efforts to remove or revise regulations that prohibit conduct having a disparate impact without evidence of discriminatory intent. Through this rule, HUD is proposing to remove provisions in HUD's Title VI implementing regulations that impose disparate-impact liability on recipients of HUD Federal financial assistance. If finalized, this rule would improve consistency within HUD's own regulations and between HUD's regulations and the Title VI regulations recently revised by the Department of Justice (DOJ). This rule reopens the public comment period of HUD's January 2026 proposed rule on disparate-impact liability; HUD will only consider comments on topics related to this supplemental notice of proposed rulemaking during the reopened comment period.
2026-13939, Rescission of Floodplain Management and Protection of Wetlands; Minimum Property Standards for Flood Hazard Exposure; Building to the Federal Flood Risk Management Standard
HUD is rolling back its 2024 floodplain and wetland protection rules to how things were before, thanks to a new executive order. This change affects builders, developers, and communities by easing some flood risk rules but keeping helpful flexibilities. Comments on this proposal are open until September 8, 2026, so now’s the time to weigh in!
2026-08406, HOME Investment Partnerships Program: Further Program Updates and Streamlining
HUD is updating the HOME Investment Partnerships Program to make it simpler and more flexible, especially for green building projects and scattered site manufactured housing rentals. These changes affect local housing groups that get federal money to build or fix affordable homes. Public comments are open until June 1, 2026, so folks can share their thoughts before the new rules take effect.
2026-08339, HOME Investment Partnerships Program: Further Program Updates and Streamlining
HUD is hitting the pause button on some new HOME program rules that were supposed to start in 2025. This delay affects local governments and housing groups waiting for updated rules about affordable housing projects. No new changes or money moves will happen until HUD finishes reviewing and publishes the next final rule—so, hang tight!
2026-08244, Equal Access to Housing in HUD Programs Revisions
HUD is updating its rules to focus on biological sex instead of gender identity when it comes to housing programs. This means shelters and similar places can ask for proof of sex to keep everyone safe. These changes affect people using HUD housing services and those running them, with public comments open until June 29, 2026.
2026-06926, HOME Investment Partnerships Program-Maximum Per-Unit Subsidy Limit Methodology and Amount; Notice for Comment
HUD is updating how it sets the maximum money allowed per housing unit for the HOME Investment Partnerships Program. This change affects builders and developers using HOME funds starting May 11, 2026, and HUD wants your thoughts before finalizing it. The new limits help make sure funds stretch fairly and wisely to build affordable homes.
Previous / Next Documents
Previous: 2026-09264, Self-Regulatory Organizations; BOX Exchange LLC; Notice of Filing and Immediate Effectiveness of a Proposed Rule Change To Establish Fees for Industry Members Related to Reasonably Budgeted CAT Costs of the National Market System Plan Governing the Consolidated Audit Trail for the Period From May 1, 2026 Through December 31, 2026
Starting May 1, 2026, BOX Exchange is charging industry members a tiny fee of $0.000001 per share to help cover the costs of the Consolidated Audit Trail (CAT) system. This fee will last through the end of December 2026 and aims to cover about two-thirds of the CAT’s budgeted expenses. Brokers will see their first bill in June based on May’s trades, so it’s time to get ready for this new charge!
Next: 2026-09267, Clostridioides Difficile Infection: Developing Drugs for Treatment, Reduction of Recurrence, or Prevention; Guidance for Industry; Availability
The FDA just released new guidance to help drug makers create medicines that treat, prevent, or stop Clostridioides difficile infections (CDI) from coming back. This update affects companies working on CDI drugs and aims to speed up safe, effective treatments reaching patients. The guidance is official as of May 11, 2026, and could save time and money by clarifying what’s needed for drug approval.